Inclusion: advanced NSCLC, EGFR wild type and EML4-ALK fusion-negative, ECOG 0–1.Exclusion: symptomatic central nervous system metastases, use of corticosteroids,* interstitial lung disease or active infection. This evidence concerns the gene EML4 and interstitial lung disease.